Prakt. lékáren. 2022; 18(2): 79-81 | DOI: 10.36290/lek.2022.016

Myths and facts about hormonal contraception

Daniel Bobek, Martin Šíma, Ondřej Slanař
Farmakologický ústav, 1. lékařská fakulta Univerzity Karlovy a Všeobecná fakultní nemocnice v Praze

Since the 1960s, hormonal contraception has played an important role in the lives of many young women. Despite the fact that properly indicated contraception contributes to both the physical and mental health of women and for many of them is an excellent protection against unplanned pregnancy, it is rejected by some because of concerns that are not always supported by today's evidence-based medicine. Even hormonal contraceptives have side effects a rational discussion with doctor is necessary to allow each woman to make an informed decision about her choice of protection from unplanned pregnancy.

Keywords: hormonal contraception, adverse effects, cancer, thrombosis, fertility.

Published: June 22, 2022  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Bobek D, Šíma M, Slanař O. Myths and facts about hormonal contraception. Praktické lékárenství. 2022;18(2):79-81. doi: 10.36290/lek.2022.016.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Ústav zdravotnických informací a statistiky České republiky. Zdravotnická ročenka České republiky 2019. Avalible from: https://www.uzis.cz/res/f/008381/zdrroccz2019.pdf.
    2. De Leo V, Musacchio MC, Cappelli V, Piomboni P, Morgante G. Hormonal contraceptives: pharmacology tailored to women's health. Hum Reprod Update. 2016;22(5):634-646. Go to original source... Go to PubMed...
    3. Le Guen M, Schantz C, Regnier­‑Loilier A, de La Rochebrochard E. Reasons for rejecting hormonal contraception in Western countries: A systematic review. Soc Sci Med. 2021;284:114247. Go to original source... Go to PubMed...
    4. Barriga P, Vanhauwaert P, Porcile A. Hormonal contraception and risk of breast cancer: a critical look. Gynecol Endocrinol. 2019;35(6):460-462. Go to original source... Go to PubMed...
    5. Girum T, Wasie A. Return of fertility after discontinuation of contraception: a systematic review and meta­‑analysis. Contracept Reprod Med. 2018;3:9. Go to original source... Go to PubMed...
    6. Sacco S, Merki­‑Feld GS, KL AE, Bitzer J, Canonico M, Kurth T, Lampl C, Lidegaard O, Anne MacGregor E, MaassenVanDenBrink A, Mitsikostas DD, Nappi RE, Ntaios G, Sandset PM, Martelletti P, European Headache F, the European Society of C, Reproductive H. Hormonal contraceptives and risk of ischemic stroke in women with migraine: a consensus statement from the European Headache Federation (EHF) and the European Society of Contraception and Reproductive Health (ESC). J Headache Pain. 2017;18(1):108. Go to original source... Go to PubMed...
    7. Voedisch AJ, Hindiyeh N. Combined hormonal contraception and migraine: are we being too strict? Curr Opin Obstet Gynecol. 2019;31(6):452-458. Go to original source... Go to PubMed...
    8. Gallo MF, Lopez LM, Grimes DA, Carayon F, Schulz KF, Helmerhorst FM. Combination contraceptives: effects on weight. Cochrane Database Syst Rev. 2014(1):CD003987. Go to original source...
    9. Simmons KB, Edelman AB. Hormonal contraception and obesity. Fertility and sterility. 2016;106(6):1282-1288. Go to original source... Go to PubMed...
    10. Both S, Lew­‑Starowicz M, Luria M, Sartorius G, Maseroli E, Tripodi F, Lowenstein L, Nappi RE, Corona G, Reisman Y, Vignozzi L. Hormonal Contraception and Female Sexuality: Position Statements from the European Society of Sexual Medicine (ESSM). J Sex Med. 2019;16(11):1681-1695. Go to original source... Go to PubMed...
    11. Fruzzetti F, Fidecicchi T. Hormonal Contraception and Depression: Updated Evidence and Implications in Clinical Practice. Clinical drug investigation. 2020;40(12):1097-1106. Go to original source... Go to PubMed...
    12. Robakis T, Williams KE, Nutkiewicz L, Rasgon NL. Hormonal Contraceptives and Mood: Review of the Literature and Implications for Future Research. Curr Psychiatry Rep. 2019;21(7):57. Go to original source... Go to PubMed...
    13. Khialani D, Rosendaal F, Vlieg AVH. Hormonal Contraceptives and the Risk of Venous Thrombosis. Semin Thromb Hemost. 2020;46(8):865-871. Go to original source... Go to PubMed...
    14. Practice Committee of the American Society for Reproductive Medicine. Electronic address Aao, Practice Committee of the American Society for Reproductive M. Combined hormonal contraception and the risk of venous thromboembolism: a guideline. Fertility and sterility. 2017;107(1):43-51. Go to original source... Go to PubMed...
    15. Tepper NK, Whiteman MK, Marchbanks PA, James AH, Curtis KM. Progestin­‑only contraception and thromboembolism: A systematic review. Contraception. 2016;94(6):678-700.
    16. Glisic M, Shahzad S, Tsoli S, Chadni M, Asllanaj E, Rojas LZ, Brown E, Chowdhury R, Muka T, Franco OH. Association between progestin­‑only contraceptive use and cardiometabolic outcomes: A systematic review and meta­‑analysis. Eur J Prev Cardiol. 2018;25(10):1042-1052. Go to original source... Go to PubMed...
    17. Elliman A. Interactions with hormonal contraception. Br J Fam Plann. 2000;26(2):109-111, quiz 111,122. Go to original source... Go to PubMed...
    18. Simmons KB, Haddad LB, Nanda K, Curtis KM. Drug interactions between non­‑rifamycin antibiotics and hormonal contraception: a systematic review. Am J Obstet Gynecol. 2018;218(1):88-97 e14. Go to original source... Go to PubMed...
    19. Gunaratne M, Thorsteinsdottir B, Garovic VD. Combined Oral Contraceptive Pill­‑Induced Hypertension and Hypertensive Disorders of Pregnancy: Shared Mechanisms and Clinical Similarities. Current hypertension reports. 2021;23(5):29. Go to original source... Go to PubMed...

    Return to the content


    Pharmacy for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.